Effects of liraglutide and empagliflozin added to insulin therapy in patients with type 2 diabetes: A randomized controlled study.

Hirotatsu NakaguchiYoshinobu KondoMayu KyoharaHiromi KonishiKoji OiwaYasuo Terauchi

Published in: Journal of diabetes investigation (2020)

Liraglutide addition to ongoing insulin therapy more effectively reduced glycated hemoglobin and glycated albumin levels than empagliflozin in patients with inadequately controlled type 2 diabetes.

Keyphrases

type diabetes
glycemic control
cardiovascular disease
adipose tissue
cell therapy
skeletal muscle
bone marrow
weight loss
red blood cell